Dexamethasone clinical trials

Explore recruiting dexamethasone clinical trials.

Recruiting dexamethasone studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dexamethasone trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HOVON 147 MM: Carfilzomib, Lenalidomide and Dexamethasone versus Lenalidomide and Dexamethasone in High- Risk Smoldering Multiple Myeloma: A Randomized Phase 2 Study.

Norway, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 as Monotherapy, in Combination With Dexamethasone, Dexamethasone/Carfilzomib, Dexamethasone/Daratumumab, and Dexamethasone/Pomalidomide in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14)

France, Germany, Italy, Greece, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Immunomodulatory effects of dexamethasone, tocilizumab and anakinra during experimental human endotoxemia: the DEDICATE-LPS study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

CYPENZA - A prospective cohort trial on antiandrogens influences on the pharmacokinetics of corticosteroids.

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effect of early dexamethasone on major complications and all-cause mortality in severe burns

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of the omission of dexamethasone in premedication regimens during paclitaxel treatment

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Dexamethasone trials by city

Dexamethasone in Toronto Dexamethasone in Vancouver Dexamethasone in Montreal Dexamethasone in Calgary Dexamethasone in Edmonton Dexamethasone in Ottawa Dexamethasone in Winnipeg Dexamethasone in Quebec City Dexamethasone in Hamilton Dexamethasone in Kitchener Dexamethasone in London Dexamethasone in Halifax Dexamethasone in New York Dexamethasone in Los Angeles Dexamethasone in Chicago Dexamethasone in Houston

Dexamethasone clinical trials

Recruiting dexamethasone studies right now

Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols

KCD (Carfilzomib/Cyclophosphamide/Dexamethasone) Regimen for the Treatment of Newly Diagnosed POEMS Syndrome

A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

Added Value of a Neuroendocrine Test Battery in the Response to Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma